Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 billion – Reuters.comRead More
Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for 14 billion Reuterscom
Related Posts
/cloudfront-us-east-2.images.arcpublishing.com/reuters/BKVVESHAONL7NBEZND52UKNV44.jpg)
Beyond Meat cuts annual revenue forecast as faux meat demand dips Reuters
Beyond Meat (BYND.O) cut annual revenue forecast and missed second-quarter net sales estimates, as slowing demand for its pricier plant-based meat products shows no signs of recove…
/cloudfront-us-east-2.images.arcpublishing.com/reuters/5QA7YPGSNNONBGJJLXTCUGOKMQ.jpg)
Limited Gaza evacuations via Rafah to be allowed after Qatar brokers deal source Reuterscom
Qatar has mediated an agreement between Egypt, Israel and Hamas, in coordination with the U.S., which will allow limited evacuations from besieged Gaza, a source briefed on the deal told…
South Korean leaders security chief warns against violent attempts to arrest Yoon Reuters
Park Chong-jun was questioned by police over his role in last week's standoff.